Skip to main navigation
Otonomy Logo
menu

Site - Top Menu

  • About
  • Our Science
  • Neurotology
  • Pipeline
  • Patient Resources
  • Investors
    • « Back
    • Overview
    • News & Events
      • Press Releases
      • Presentations
      • Events
    • Financial Information
      • SEC Filings
      • Annual Reports & Proxies
    • Investor Resources
      • Investor FAQs
      • E-mail Alerts
      • Contact Us
    • Corporate Governance
    • Stock Information and Analyst Coverage

News & Events

Press Releases Presentations Events

Press releases

  • May 18, 2022 Otonomy to Participate in the H.C. Wainwright Global Investment Conference
  • May 12, 2022 Otonomy Announces OTO-825 Presentation at the American Society of Gene & Cell Therapy Annual Meeting
  • May 09, 2022 Otonomy Reports First Quarter 2022 Financial Results and Provides Corporate Update
  • May 02, 2022 Otonomy to Report First Quarter 2022 Financial Results and Provide Corporate Update
  • Apr 20, 2022 Otonomy Reports Positive Top-Line Results from Phase 2a Clinical Trial of OTO-413 in Patients with Hearing Loss
  • Mar 15, 2022 Otonomy to Host Virtual Investor R&D Event on March 22, 2022
  • Feb 28, 2022 Otonomy Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
  • Feb 28, 2022 Otonomy to Participate in Two Upcoming Investor Conferences
  • Feb 25, 2022 Otonomy to Host Virtual Investor R&D Event on March 22, 2022
  • Feb 22, 2022 Otonomy Completes Enrollment in Phase 2 Clinical Trial of OTO-313 in Tinnitus

Pagination

  • Current page 1
  • Page 2
  • Next page next ›
  • Last page last »
X
  • Facebook
  • LinkedIn
  • Google
  • Careers
  • Contact
  • Terms of Use
  • Privacy Policy
©2022 Otonomy